Tatva Chintan Pharma Chem Ltd vs Tgv Sraac Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 23, 2026

Key Highlights

The Latest Trading Price of Tatva Chintan Pharma Chem Ltd is ₹ 1127 as of 20 Mar 15:30 . The P/E Ratio of Tatva Chintan Pharma Chem Ltd changed from 53.4 on March 2022 to 278.3 on March 2025 . This represents a CAGR of 51.09% over 4 yearsThe P/E Ratio of TGV Sraac Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Tatva Chintan Pharma Chem Ltd changed from ₹ 5115 crore on March 2022 to ₹ 1588 crore on March 2025 . This represents a CAGR of -25.35% over 4 yearsThe Market Cap of TGV Sraac Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 133.07 crore as compare to the Sep '25 revenue of ₹ 124.52 crore. This represent the growth of 6.87% The revenue of TGV Sraac Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 27.22 crore as compare to the Sep '25 ebitda of ₹ 23.22 crore. This represent the growth of 17.23% The ebitda of TGV Sraac Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Tatva Chintan Pharma Chem Ltd changed from ₹ 5.21 crore to ₹ 15.17 crore over 7 quarters. This represents a CAGR of 84.17% The net profit of TGV Sraac Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Tatva Chintan Pharma Chem Ltd changed from 19.56 % on March 2021 to 708.79 % on March 2025 . This represents a CAGR of 105.04% over 5 yearsThe Dividend Payout of TGV Sraac Ltd changed from 2.96 % on March 2023 to 11.63 % on March 2025 . This represents a CAGR of 57.80% over 3 years .

About Tatva Chintan Pharma Chem Ltd

Tatva Chintan Pharma Chem Limited was formerly incorporated as 'Tatva Chintan Pharma Chem Private Limited' on 12 June 1996.
The status of the Company converted from Private Limited into a Public Limited Company from 27 January 2021 and the name of Company changed from 'Tatva Chintan Pharma Chem Private Limited' to 'Tatva Chintan Pharma Chem Limited'.
The Company is promoted by Mr. Chintan Nitin Kumar Shah, Mr. Ajay Kumar Mansukhlal Patel and Mr. Shekhar Rasiklal Somani. The Company is a globally recognized specialty chemical player with several market leading products in its portfolio.
The Company is primarily engaged in manufacturing, distribution and selling of specialty chemicals i.e., Phase Transfer Catalysts (PTC), Structure Directing Agents (SDA), Electrolyte Salts and Solutions (ESS), Pharmaceutical and Agrochemical Intermediates and Other Specialty Chemicals (PASC).

About TGV Sraac Ltd

TGV Sraac Limited, formerly known as Sree Rayalaseema Alkali and Allied Chemicals Limited was incorporated on 24th June, 1981.
The name of Company was changed from 'Sree Rayalaseema Alkali and Allied Chemicals Limited' to 'TGV Sraac Limited' in September, 2017.
Company is the leading producer of Chlor'Alkali Chemicals, Chloromethanes and also manufactures Castor Derivatives and Fatty Acids.
It manufactures Caustic Soda, Liquid Chlorine, Hydrochloric Acid, Hydrogen and Barium Sulphate. The company started commercial production in Aug.'88 with an initial installed capacity of 22,440 tpa of caustic soda.
Presently the company has the capacity to produce 69500 TPA of caustic soda The company uses Bipolar Membrane Cell Technology, the latest one in the world for the manufacture of caustic soda and allied products.

FAQs for the comparison of Tatva Chintan Pharma Chem Ltd and TGV Sraac Ltd

Which company has a larger market capitalization, Tatva Chintan Pharma Chem Ltd or TGV Sraac Ltd?

Market cap of Tatva Chintan Pharma Chem Ltd is 2,637 Cr while Market cap of TGV Sraac Ltd is 886 Cr

What are the key factors driving the stock performance of Tatva Chintan Pharma Chem Ltd and TGV Sraac Ltd?

The stock performance of Tatva Chintan Pharma Chem Ltd and TGV Sraac Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Tatva Chintan Pharma Chem Ltd and TGV Sraac Ltd?

As of March 23, 2026, the Tatva Chintan Pharma Chem Ltd stock price is INR ₹1127.45. On the other hand, TGV Sraac Ltd stock price is INR ₹82.74.

How do dividend payouts of Tatva Chintan Pharma Chem Ltd and TGV Sraac Ltd compare?

To compare the dividend payouts of Tatva Chintan Pharma Chem Ltd and TGV Sraac Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.